GREEK PATENT: Pentablock Polypeptidic and Hybrid Polymers to gige In Situ-Forming Injectable, Self-Healing pH- and Temperature-Responsive Hydrogels for Localized Targeted Delivery of Gemcitabine.

Greek Patent No: 1009114 and INT CL: A61K 47/34, C08G 69/36.